vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
CAPRICOR THERAPEUTICS, INC.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.5倍（$11.1M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -63.9%，领先61.9%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -7.9%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-15.3M），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs 1.9%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
CAPR vs RMCF — 直观对比
损益表 — Q4 FY2024 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $7.5M |
| 净利润 | $-7.1M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -69.1% | 1.1% |
| 净利率 | -63.9% | -2.1% |
| 营收同比 | -7.9% | -4.4% |
| 净利润同比 | -833.8% | 81.7% |
| 每股收益（稀释后） | $-0.11 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | $6.8M | ||
| Q2 25 | — | $6.4M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $11.1M | $7.9M | ||
| Q3 24 | $2.3M | $6.4M | ||
| Q2 24 | $4.0M | $6.4M | ||
| Q1 24 | $4.9M | $7.3M |
| Q4 25 | — | $-155.0K | ||
| Q3 25 | — | $-662.0K | ||
| Q2 25 | — | $-324.0K | ||
| Q1 25 | — | $-2.9M | ||
| Q4 24 | $-7.1M | $-847.0K | ||
| Q3 24 | $-12.6M | $-722.0K | ||
| Q2 24 | $-11.0M | $-1.7M | ||
| Q1 24 | $-9.8M | $-1.6M |
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | -7.0% | ||
| Q2 25 | — | -2.3% | ||
| Q1 25 | — | -30.3% | ||
| Q4 24 | -69.1% | -8.9% | ||
| Q3 24 | -575.2% | -14.3% | ||
| Q2 24 | -291.9% | -25.4% | ||
| Q1 24 | -209.2% | -21.7% |
| Q4 25 | — | -2.1% | ||
| Q3 25 | — | -9.7% | ||
| Q2 25 | — | -5.1% | ||
| Q1 25 | — | -32.5% | ||
| Q4 24 | -63.9% | -10.7% | ||
| Q3 24 | -555.2% | -11.3% | ||
| Q2 24 | -277.0% | -25.9% | ||
| Q1 24 | -199.6% | -21.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.38 | ||
| Q4 24 | $-0.11 | $-0.11 | ||
| Q3 24 | $-0.38 | $-0.11 | ||
| Q2 24 | $-0.35 | $-0.26 | ||
| Q1 24 | $-0.31 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $6.0M |
| 总资产 | $170.5M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $641.0K | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | — | $893.0K | ||
| Q1 25 | — | $720.0K | ||
| Q4 24 | $151.5M | $1.1M | ||
| Q3 24 | $85.0M | $973.0K | ||
| Q2 24 | $29.5M | $637.0K | ||
| Q1 24 | $39.9M | $2.1M |
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | — | $6.7M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | $145.5M | $9.8M | ||
| Q3 24 | $68.3M | $10.5M | ||
| Q2 24 | $11.5M | $9.0M | ||
| Q1 24 | $18.4M | $10.6M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | — | $22.3M | ||
| Q2 25 | — | $20.1M | ||
| Q1 25 | — | $21.2M | ||
| Q4 24 | $170.5M | $21.6M | ||
| Q3 24 | $93.0M | $21.1M | ||
| Q2 24 | $38.3M | $19.0M | ||
| Q1 24 | $49.4M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | $-1.3M |
| 自由现金流率自由现金流/营收 | -137.3% | -16.9% |
| 资本支出强度资本支出/营收 | 4.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $-1.2M | ||
| Q3 25 | — | $-488.0K | ||
| Q2 25 | — | $350.0K | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $-14.8M | $-2.1M | ||
| Q3 24 | $-11.6M | $-3.5M | ||
| Q2 24 | $-12.3M | $-2.2M | ||
| Q1 24 | $-1.3M | $129.0K |
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | — | $182.0K | ||
| Q1 25 | — | — | ||
| Q4 24 | $-15.3M | — | ||
| Q3 24 | $-11.7M | $-4.6M | ||
| Q2 24 | $-12.3M | $-2.6M | ||
| Q1 24 | $-1.9M | $-352.3K |
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | -137.3% | — | ||
| Q3 24 | -515.2% | -72.6% | ||
| Q2 24 | -310.9% | -40.2% | ||
| Q1 24 | -38.3% | -4.9% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 0.4% | 17.5% | ||
| Q2 24 | 1.5% | 6.5% | ||
| Q1 24 | 12.4% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
